Skip to content

The Association between Intravenous Lipid Emulsion Types, Infusion Modalities and clinical efficacy and safety in China: A Multicenter, Real-World Study Based on Electronic Medical Data from Hospital Information Systems

The Association between Intravenous Lipid Emulsion Types, Infusion Modalities and clinical efficacy and safety in China: A Multicenter, Real-World Study Based on Electronic Medical Data from Hospital Information Systems

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112507
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients using parenteral nutrituion fat emulsions

Interventions

Inpatient group receiving intravenous infusion of fish oil fat emulsion:none
Inpatient group without intravenous infusion of fish oil fat emulsion:none

Sponsors

Suzhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. During hospitalization, the patient received at least one parenteral-nutrition lipid emulsion marketed in China, including long-chain triglyceride (LCT) emulsion, medium-/long-chain triglyceride (MCT/LCT) emulsion, olive-oil–based emulsion, structured triglyceride emulsion, multi-oil emulsion, or fish-oil emulsion, as well as triple-chamber bags containing any of these lipid emulsions. 2. Detailed inpatient records must be obtainable, covering admission and discharge diagnoses, height and weight at admission and discharge, all prescription information during the stay, and laboratory test results.

Exclusion criteria

Exclusion criteria: 1.patients not using lipid emulsion;

Design outcomes

Primary

MeasureTime frame
immune/inflammation response;

Secondary

MeasureTime frame
nutritional status;

Countries

China

Contacts

Public ContactQin Huanlong

Suzhou Municipal Hospital

huanlong_qin@live.com+86 21 66301161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026